Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $134.89 million. The enterprise value is $183.69 million.
| Market Cap | 134.89M |
| Enterprise Value | 183.69M |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025, before market open.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.63 million shares outstanding. The number of shares has increased by 2.97% in one year.
| Current Share Class | 16.63M |
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | +2.97% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 36.37% |
| Owned by Institutions (%) | 39.32% |
| Float | 10.58M |
Valuation Ratios
The trailing PE ratio is 26.05 and the forward PE ratio is 10.27.
| PE Ratio | 26.05 |
| Forward PE | 10.27 |
| PS Ratio | 0.78 |
| Forward PS | 0.62 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | 7.65 |
| P/OCF Ratio | 6.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.09, with an EV/FCF ratio of 10.42.
| EV / Earnings | 34.75 |
| EV / Sales | 1.06 |
| EV / EBITDA | 13.09 |
| EV / EBIT | 19.36 |
| EV / FCF | 10.42 |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.42.
| Current Ratio | 3.22 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | 3.26 |
| Interest Coverage | 3.87 |
Financial Efficiency
Return on equity (ROE) is 4.05% and return on invested capital (ROIC) is 3.38%.
| Return on Equity (ROE) | 4.05% |
| Return on Assets (ROA) | 2.93% |
| Return on Invested Capital (ROIC) | 3.38% |
| Return on Capital Employed (ROCE) | 4.93% |
| Revenue Per Employee | $258,234 |
| Profits Per Employee | $7,878 |
| Employee Count | 671 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, Ultralife has paid $1.76 million in taxes.
| Income Tax | 1.76M |
| Effective Tax Rate | 24.59% |
Stock Price Statistics
The stock price has decreased by -20.41% in the last 52 weeks. The beta is 0.91, so Ultralife's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -20.41% |
| 50-Day Moving Average | 5.72 |
| 200-Day Moving Average | 7.21 |
| Relative Strength Index (RSI) | 70.29 |
| Average Volume (20 Days) | 126,597 |
Short Selling Information
The latest short interest is 383,026, so 2.30% of the outstanding shares have been sold short.
| Short Interest | 383,026 |
| Short Previous Month | 313,638 |
| Short % of Shares Out | 2.30% |
| Short % of Float | 3.62% |
| Short Ratio (days to cover) | 4.86 |
Income Statement
In the last 12 months, Ultralife had revenue of $173.28 million and earned $5.29 million in profits. Earnings per share was $0.31.
| Revenue | 173.28M |
| Gross Profit | 43.65M |
| Operating Income | 9.49M |
| Pretax Income | 12.33M |
| Net Income | 5.29M |
| EBITDA | 14.03M |
| EBIT | 9.49M |
| Earnings Per Share (EPS) | $0.31 |
Balance Sheet
The company has $8.72 million in cash and $57.51 million in debt, giving a net cash position of -$48.79 million or -$2.93 per share.
| Cash & Cash Equivalents | 8.72M |
| Total Debt | 57.51M |
| Net Cash | -48.79M |
| Net Cash Per Share | -$2.93 |
| Equity (Book Value) | 136.60M |
| Book Value Per Share | 8.20 |
| Working Capital | 69.97M |
Cash Flow
In the last 12 months, operating cash flow was $20.09 million and capital expenditures -$2.46 million, giving a free cash flow of $17.63 million.
| Operating Cash Flow | 20.09M |
| Capital Expenditures | -2.46M |
| Free Cash Flow | 17.63M |
| FCF Per Share | $1.06 |
Margins
Gross margin is 25.19%, with operating and profit margins of 5.47% and 3.05%.
| Gross Margin | 25.19% |
| Operating Margin | 5.47% |
| Pretax Margin | 4.12% |
| Profit Margin | 3.05% |
| EBITDA Margin | 8.10% |
| EBIT Margin | 5.47% |
| FCF Margin | 10.17% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.97% |
| Shareholder Yield | -2.97% |
| Earnings Yield | 3.92% |
| FCF Yield | 13.07% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 72.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 72.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 2.12 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 4 |